Stay updated on Sacituzumab + Pembrolizumab in Metastatic TNBC Clinical Trial

Sign up to get notified when there's something new on the Sacituzumab + Pembrolizumab in Metastatic TNBC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Sacituzumab + Pembrolizumab in Metastatic TNBC Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    Version updated from v3.0.1 to v3.0.2, indicating a minor release. The 'Back to Top' link was removed; no other core content changes were detected.
    Difference
    0.1%
    Check dated 2025-09-14T23:18:04.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes in core content, names, pricing, or availability.
    Difference
    0.1%
    Check dated 2025-09-07T19:54:48.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    The page has undergone significant changes, including the addition of a facility name and location details, as well as the introduction of new drug names such as sacituzumab govitecan and pembrolizumab. However, several related topics and previous location details have been removed.
    Difference
    2%
    Check dated 2025-08-31T12:44:13.000Z thumbnail image
  4. Check
    23 days ago
    No Change Detected
  5. Check
    30 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.11 to version 2.16.12, indicating a revision in the content.
    Difference
    0.0%
    Check dated 2025-08-17T05:24:13.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The page has updated the number of study locations from 11 to 12 and changed the revision version from v2.16.10 to v2.16.11. Additionally, it includes contact information for Abirami Sivapiragasam, MD, in Charleston, South Carolina.
    Difference
    1%
    Check dated 2025-08-10T01:04:08.000Z thumbnail image
  7. Check
    44 days ago
    Change Detected
    Summary
    The web page has been updated to version 2.16.10, and a previous service alert regarding planned maintenance has been removed.
    Difference
    0.7%
    Check dated 2025-08-02T19:59:21.000Z thumbnail image

Stay in the know with updates to Sacituzumab + Pembrolizumab in Metastatic TNBC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Sacituzumab + Pembrolizumab in Metastatic TNBC Clinical Trial page.